iTonic Holdings Ltd.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $28.4M
- Price
- $4.15
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.97%
- Volume
- 31.8K
About
iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size. Key among its offerings is FTTPS, a sophisticated treatment planning system engineered for diverse malignant tumors. This system excels at defining the target volume, determining the prescribed dose, establishing safety margins for organs at risk, and formulating a precise dose distribution plan essential for brachytherapy patients. Founded in Beijing, China, in 1998, the company operated as Pheton Holdings Ltd. until its rebranding to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. functions as a subsidiary of ZJW (BVI) LTD.
Quick stats
Shares outstanding6.8M
Computed float582.7K
Float / shares8.5%
Cash runway (months)3.1
Key info
SectorHealthcare
IndustryMedical - Specialties
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001970544
Websitehttp://www.ftzy.com.cn
AI Summary
AI-generated1/50
majorbearishreverse split
iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026
iTonic Holdings will execute a 16-for-1 share consolidation of its Class A and Class B ordinary shares effective October 6, 2026, with shares continuing to trade under the ITOC symbol on Nasdaq.
Outstanding Class A shares fall from 109,382,000 to roughly 6.84 million and Class B shares from 7,668,000 to about 479,250; a new CUSIP (G71399110) replaces the old one, and options, warrants, and convertibles will be proportionately adjusted.
The consolidation is explicitly aimed at lifting the per-share price to regain compliance with Nasdaq's $1.00 minimum bid rule, with a compliance deadline of October 19, 2026, and the company concedes there is no assurance of success.
A concurrent share capital increase raises authorized shares to 400 million Class A and 100 million Class B, creating a large authorized-but-unissued reserve that could support future dilution.
Red flags
- 16-for-1 reverse split signals Nasdaq listing compliance risk ($1.00 minimum bid rule)
- compliance deadline of October 19, 2026 leaves a very short window post-split
- company explicitly states there is no assurance of regaining or maintaining compliance
- authorized share capital increase to 400M Class A / 100M Class B creates headroom for future dilution